Table 3. Q values for reported symptoms in pre-vaccinated participants.
Antigens/Controls | Antigen Abbreviation | Anosmia/Ageusia N = 21/41 (51%) | Cough N = 21/41 (51%) | Fever N = 23/41 (56%) |
---|---|---|---|---|
SARS-CoV-2 Proteins | NCP | 0.0084* | 0.0886 | 0.1664 |
NTD | 0.0064* | 0.0462* | 0.0568 | |
RBD1 | 0.0064* | 0.0462* | 0.0462* | |
RBD2 | 0.0064* | 0.0275* | 0.0540 | |
ST4 | 0.0064* | 0.0338* | 0.0462* | |
SARS-CoV-2 RBD Mutant Proteins | D614G | 0.0064* | 0.0338* | 0.0315* |
F490S | 0.0963 | 0.0540 | 0.0945 | |
N460K | 0.0064* | 0.0462* | 0.0886 | |
E484Q | 0.0064* | 0.0462* | 0.1345 |